Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Complete Revascularization Strategies Using Sirolimus Eluting Biodegradable Polymer Coated Stents in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease

NCT03621501 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT03621501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03621501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Complete Revascularization Strategies Using Sirolimus Eluting Biodegradable Polymer Coated Stents in Patients Presenting With Acute Coronary Syndrome and Multivessel Disease
Lead sponsor
Erasmus Medical Center
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 22, 2018
Completion date
October 31, 2026
Enrollment
1,525 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome